智通财经APP讯,大理药业(603963.SH)发布股价异动公告称,公司参麦注射液未中选湖北19省中成药省际联盟采购,参麦注射液原有等级医院市场的销量基本全部失去。公司醒脑静注射液中了广东6省中成药联盟集采备选,醒脑静注射液在联盟6省销量将有较大比例下滑。公司醒脑静注射液已中选全国中成药采购联盟集中带量采购,虽然销量逐步回升,但由于销售价格大幅下降,导致毛利减少。
特别声明:以上内容(如有图片或视频亦包括在内)为自媒体平台“网易号”用户上传并发布,本平台仅提供信息存储服务。
Notice: The content above (including the pictures and videos if any) is uploaded and posted by a user of NetEase Hao, which is a social media platform and only provides information storage services.